- Tytuł:
- POSA57 Axicabtagene Ciloleucel and Tisagenlecleucel for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Spain: A Cost-Effectiveness Analysis
- Autorzy:
- Źródło:
- In Value in Health January 2022 25(1) Supplement:S44-S44
Czasopismo naukowe